EasyNAT Malaria: a simple, rapid method to detect Plasmodium species using cross-priming amplification technology

Area of Science:

• Molecular diagnostics
• Infectious disease detection
• Parasitology

Background:

• Malaria remains a significant global health threat, necessitating advanced detection technologies for effective control.
• Current diagnostic methods like microscopy and rapid diagnostic tests (RDTs) have limitations in sensitivity and speed.
• Accurate and rapid malaria detection is vital for preventing transmission and reducing disease burden.

Purpose of the Study:

• To establish and validate the EasyNAT Malaria Assay, a novel molecular detection method.
• To evaluate the diagnostic accuracy and clinical performance of EasyNAT Malaria Assay against established methods.
• To assess the assay's utility for rapid screening of malaria in clinical settings.

Main Methods:

• The EasyNAT Malaria Assay was developed targeting Plasmodium species (P. vivax, P. falciparum, P. ovale, P. malariae).
• Analytical performance was assessed using positive materials, with a limit of detection (LOD) of 40 parasites/mL.
• Clinical validation involved testing 137 samples against light microscopy, RDT, and digital PCR.

Main Results:

• EasyNAT Malaria Assay demonstrated reliable repeatability and reproducibility, specifically amplifying Plasmodium.
• The assay identified more positive cases than microscopy (4 more) and RDT (2 more) in clinical samples.
• High concordance rates with microscopy were observed (97.08% total, 100% positive, 95.79% negative).

Conclusions:

• The EasyNAT Malaria Assay is an efficient molecular detection tool with good clinical performance.
• It shows enhanced diagnostic accuracy, particularly in patients with prior anti-malarial treatment.
• The assay is suitable for rapid screening of high-risk populations in emergency settings, aiding malaria control efforts.